Lonza

Lonza at DCAT Week 2025! We are thrilled to attend DCAT Week 2025 in New York City from March 17-20! DCAT (Drug, Chemical & Associated Technologies Association) Week is a premier event for the pharmaceutical and chemical industries, bringing together industry leaders, innovators, and professionals from around the globe. Our team is excited to engage in insightful discussions, explore new opportunities, and showcase our latest advancements in biopharmaceutical development and manufacturing. Don't miss the chance to connect with the team on site! Schedule a meeting with the Lonza team (https://lnkd.in/dCi_y7Db) to discuss how we can collaborate and drive innovation together. We look forward to seeing you there! #DCATWeek2025 #Lonza #DCAT2025 #Outsourcing #CDMO #MakingtheMedicinesofTomorrow

Join our webinar: Industrialization of AAV Manufacturing with Xcite® Platforms. Selecting the right manufacturing approach for AAV production is key to achieving productivity and scalability goals. In this webinar, our experts will explore strategies to meet productivity targets efficiently and insights into achieving superior and scalable AAV production. 📅 Date: March 19, 2025 ⏰ Time: 8am PDT / 11am EDT / 3pm GMT / 4pm CET Register today to secure your spot: https://lnkd.in/eRmAN4SM #aav #genetherapy #LonzaCGT #RealizingPotentialTogether

We will be presenting at the upcoming 3rd Annual Viral Vector Process Development & Manufacturing Summit. Join our expert Peng Wang, Ph.D. who will explore the Industrialization of AAV Manufacturing by Xcite® Transient and Stable Production Platforms, providing insight to the development of AAV stable PCL with superior productivity. 📅 Date: Thursday, 20 February 2025 ⏰ Time: 12.30pm – 1.30pm ET 📍 Where: 3rd Annual Viral Vector Process Development & Manufacturing Summit Aren’t attending the summit? Our team will be in the Boston area and will be delivering a Lunch & Learn workshop AAV Lunch & Learn workshop, discussing more about our AAV platform and manufacturing capabilities. This is a fantastic opportunity to connect with our R&D innovators, licensing team, and manufacturing experts to gain insight into the latest platform data. Places are limited. 📅 Date: Tuesday, 18 February 2025 ⏰ Time: 11.00am – 1.30pm ET 📍 Where: CIC Cambridge – Boston 🔗 Save your spot: https://lnkd.in/er2VVtSc #Genetherapy #Celltherapy #LonzaCGT #RealizingPotentialTogether

"Our strategy is quite simple: we focus on building out next-generation technology, bringing cutting-edge product innovations to market, and delighting customers with best-in-industry services." Frank Romanski, Executive Director of Strategic Programs at Lonza Capsules & Health Ingredients, spoke to Nutrition Insight about how our focus on innovation and service can overcome bioavailability challenges and bring some of the most challenging formulations to life. Watch the full interview here: https://lnkd.in/dKaKqeS6

What makes working in science special? Today is the 10th anniversary of the International Day of Women and Girls in Science. Lara Nonis, Anmol Mhay and Sneha Arora shared their experience of what it looks like to be a scientist working in industry, and how creativity and curiosity can help to make a meaningful difference. #AMeaningfulDifference #Innovation #IDWGS #WomenInScience #GirlsInScience

"The way we run our operations impacts every product metric – quality, cost, reliability, safety, and even sustainability – and advanced process technologies provide tools to optimize them all." Niklaus Künzle, Senior Director of Process Technologies & Innovation at Lonza, speaks about how technological innovations paired with subtle tweaks to processes can benefit projects and operations in our latest R&D blog. Read the full article here: https://lnkd.in/dgWw2ThB #Lonza #CDMO #Innovation #ProcessImprovement #PharmaceuticalManufacturing

Selecting the right lead form of your API is crucial for accelerating market entry. Join our upcoming free webinar hosted by Life Science Connect on Tuesday, February 18, at 11 AM EST / 5 PM CET, where Lonza’s solid form experts Mariam Ibrahim, Kelly Shunje, PhD., and Jordan Oliver will present a case study describing the selection of the optimal solid form of an API designed for pulmonary administration. In this session, you will learn how to:  ·      Identify viable salt/cocrystal forms for micronization feasibility and enhancing solubility ·      Evaluate material performance during processing/micronizing ·      Determine critical selection criteria for the lead micronized form to proceed to preclinical studies   You can register here: https://lnkd.in/d4dnB449.    #MicronizationWebinar #LonzaSM #WeWorkAsOne

Are you ready to advance your therapeutic delivery with engineered extracellular vesicles? We are thrilled to invite you to meet the experts presenting a case study utilizing novel linking and loading technologies to enable the precision engineering of extracellular vesicles (EVs) for gene therapies. 📅 Date: Thursday, 13 February 2025 🕒 Time: 11:00 EST / 17:00 CET 📍 Location: Online Don't miss this chance to gain valuable insights and connect with industry experts. Register now and secure your spot! 🔗 https://lnkd.in/dKy3HHFP We look forward to seeing you there! #Lonza #LonzaExpressionSystems #LonzaCGT #extracellularvesicles #geneTherapy

Pierre Reuse, Global Lead Sustainability Implementation at Lonza, recently talked to Pharma's Almanac about the four pillars of Lonza's emissions reduction strategy: Replace, Renew, Reduce, and Redesign. Read the full article here: https://lnkd.in/eYii8hUC #Lonza #CDMO #PharmaceuticalManufacturing #Sustainability

Earlier this week we shared our Full-Year 2024 financial results - delivering CER sales in line with 2023 and a 29.0% CORE EBITDA margin. We maintained strong order momentum, continued to execute our organic growth projects, and expanded our network with the addition of our Vacaville site in California (US). Alongside a solid financial performance, in December 2024 we shared our One Lonza strategy to drive future growth and further enhance customer experience. Thank you to all of the teams at Lonza who helped us to deliver for our customers and their patients in 2024. #Lonza #CDMO #Growth #PharmaceuticalManufacturing #Biotech